Recent Finacing
Recent Raise
Diartis Pharmaceuticals is a Mountain View biotech developing XTEN-fused therapeutic proteins for metabolic diseases, advancing a clinical-stage exenatide-XTEN candidate for type 2 diabetes to extend half-life and dosing interval.
Focus Areas
Recent Investors
Funding round
Investors